Abstract
In 2000 in France there were over 60,000 ex-drug addicts undergoing high-dose buprenorphine maintenance, to whom must be added those who illicitly use this drug after buying it in the street. It is thus probable that a nonnegligible number of expectant mothers can be found among these buprenorphine users. The literature is poor on the effects of this drug in the fetus (1,2), as well as the effects of the brutal cessation of exposure at birth. The results of animal studies, reported in the introductive chapter (Chapter 9), showed the absence of teratogenic and embryotoxic effects in the animal species in which it was tested.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Boobis AR, Burley D, Margerison Davies D, Davies DS, Harrison PI, Orme ME, Park BK, Goldberg LI. Buprenorphine. In: Therapeutic drugs, vol. 1, Dollery C, ed., Kent, UK, Churchill Livingstone, 1991.
Committee on Drugs of the American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics 1998; 101: 1079–88.
Marquet P, Chevrel J, Lavignasse P, Merle L, Lachâtre G. Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Ther 1997; 62: 569–71.
Jernite M, Viville B, Escande B, Brettes JP, Messer J. Grossesse et buprénorphine. À propos de 24 cas. Arch Pediatr 1999; 6: 1179–89.
Marquet P, Lavignasse P, Chevrel J, Merle L, Lachâtre G. Exposition au Subutex in utero et syndrome de manque du nouveau-né. Toxicorama 1999; 11: 17–24.
Marquet P. High-dose buprenorphine use in pregnant women and consequences for their newborn. In: Proceedings of the 52nd Annual Meeting of the American Academy of Forensic Sciences, Reno, NV, February 21–24, 2000.
Finnegan LP, Weiner SM. Drug withdrawal in the neonate. In: Neonatal intensive care. Merenstein GB, Gardner SL, eds., New York: Mosby Year Book, 1993.
Hoja H, Marquet P, Verneuil B, Lotfi H, Dupuy J-L, Dreyfuss M-F, Lachâtre G. Dosage de buprénorphine et de norbuprénorphine dans l’urine et le sérum par chromatographie liquide couplée à la spectrométrie de masse avec ionisation de type électrospray. Analusis 1996; 24: 104–7.
Hoja H, Marquet P, Verneuil B, Lotfi H, Dupuy J-L, Lachâtre G. Determination of buprenorphine and norbuprenorphine in whole blood samples by liquid chromatography mass spectrometry. J Anal Toxicol 1997; 21: 160–5.
Kintz P, Cirimele V, Pépin G, Marquet P, Deveaux M, Mura P. Identification et dosage des cannabinoides dans le sang total. Toxicorama 1996; 8 (2): 8–10.
Gaillard Y, Pépin G, Marquet P, Kintz P, Deveaux M, Mura P. Identification et dosage de benzoylecgonine, cocaïne, méthylecgonine-ester, codéine, morphine et 6-acétylmorphine dans le sang total. Toxicorama 1996; 8: 17–22.
Marquet P, Lachâtre G, Kintz P, Pépin G, Deveaux M, Mura P. Identification et dosage des principales drogues amphétaminiques dans le sang total par chromatographie en phase gazeuse couplée à la spectrométrie de masse (CPG-SM). Toxicorama 1996; 8 (2): 23–8.
Cirimele V, Kintz P, Tracqui A, Mangin P. Comparaison des techniques d’extraction de la cocaïne et des opiacés dans les cheveux. Toxicorama 1994; 6 (1): 1–10.
Jarvis M-A-E, Schnoll S-H. Methadone treatment during pregnancy. J Psychoactive Drugs 1994; 26: 155–6.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Marquet, P., Lavignasse, P., Gaulier, JM., Lachâtre, G. (2002). Case Study of Neonates Born to Mothers Undergoing Buprenorphine Maintenance Treatment. In: Kintz, P., Marquet, P. (eds) Buprenorphine Therapy of Opiate Addiction. Forensic Science and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-282-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-59259-282-1_10
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9713-7
Online ISBN: 978-1-59259-282-1
eBook Packages: Springer Book Archive